The Omega XP Laser System, a low-level laser that could help in the treatment of pain and smoking addiction, has been awarded FDA approval for use in treating certain forms of musculoskeletal tissue pain, including tendonitis.
The system is a noninvasive, portable therapeutic medical laser designed to deliver low-level, pulsing light energy to the target tissue.
Low-level laser therapy increases adenosine triphosphate (ATP) and protein synthesis, resulting in growth factor response within the cells and improved cell proliferation; increases endorphin release, thereby promoting pain relief; strengthens the immune system response by increasing lymphocyte activity; and promotes acupuncture point stimulation.
In smoking cessation, the laser is used to treat certain acupuncture points in the hands and ears that stimulate the release of endorphins, thereby inhibiting craving for tobacco and reducing or eliminating the physical nicotine withdrawal symptoms. While the device is FDA cleared specifically for use in treating tendonitis pain, the laser has proven effective in treating a wide range of conditions.